Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLBS3233 in Newly Diagnosed Type 2 Diabetes
NCT01645332Phase 3Completed
- Sponsor
- Dexa Medica
- Start
- Jul 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of DLBS3233 in type 2 diabetes mellitus (T2DM), sponsored by Dexa Medica. Started Jul 2012; status: completed.
02
Drugs
DLBS3233
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01645332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01645332.